Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2007-11-13
2007-11-13
Tsang, Cecilia J. (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C424S069000
Reexamination Certificate
active
10938197
ABSTRACT:
This invention relates to a method and compositions for treating pathological intervertebral discs comprising the step of delivering an agent that causes chemical crosslinking of the native molecular components of the disc. Supplemental materials which are susceptible to crosslinking by the aforementioned agent are optionally delivered to the disc in order to increase and maintain disc height.
REFERENCES:
patent: 4600739 (1986-07-01), Krankkala
patent: 4716224 (1987-12-01), Sakurai
patent: 4931546 (1990-06-01), Tardy
patent: 5024742 (1991-06-01), Nesburn
patent: 5306500 (1994-04-01), Rhee
patent: 5510418 (1996-04-01), Rhee
patent: 5972385 (1999-10-01), Liu
patent: 6126682 (2000-10-01), Sharkey
patent: 6165488 (2000-12-01), Tardy
patent: 6165758 (2000-12-01), Asai
patent: 6187048 (2001-02-01), Milner
patent: 6206921 (2001-03-01), Guagliano
patent: 6231608 (2001-05-01), Stone
patent: 6605570 (2003-08-01), Miller
patent: 6624245 (2003-09-01), Wallace
patent: 2002/0049498 (2002-04-01), Yuksel
patent: 2002/0176893 (2002-11-01), Wironen et al.
patent: 2003/0049301 (2003-03-01), Hedman
patent: 2003/0181365 (2003-09-01), Slivka
patent: 2004/0054414 (2004-03-01), Trieu et al.
patent: 2004/0253219 (2004-12-01), Hedman
patent: 95/34332 (1995-12-01), None
patent: WO97/26847 (1997-01-01), None
patent: WO 00/20021 (1999-07-01), None
patent: WO 00/62832 (2000-10-01), None
patent: 01/07009 (2001-01-01), None
patent: WO 01/76654 (2001-04-01), None
patent: WO 01/70151 (2001-09-01), None
patent: WO 03/020031 (2002-08-01), None
Fumihiko, Kato, Med et al, Serial hanges Observed by Magnetic Resonance Imaging in the Intervertebral Disc After Chemounucleolysis- A Consideration Of The Mechanism of Chemonucleotysis; Department of Orthopaedic Surgery, School of Medicine, Nagoya University,Nagoya City, Japan, May 20, 1991.
Juergen Kraemer, , MD & Heiko Laturnus MD; Lumbar Intradiscal Instillation With Aprotinin; SPINE vol. 7, No. 1, 1982; pp. 73-74; 1982 Harper & Row Publishers, Inc.
Eugene Khor; Methods of Treatment of Collagenous Tissues for Bioprostheses; Biomaterials 18 (1997) pp. 95-105; Elsevier Science Limited.
C.P. Pathak et al., Water Soluble Tissue Crosslinkers for Bioprostheses; 2001 Society for Biomaterials; 27thAnnual Meeting Transactions.
Gunner, Do Human Lumbar Discs Reconstitute After Chemonucleolysis, Spine, 1999, pp. 342-248, vol. 24, No. 4, Lippincott, Williams & Wilkins, Inc.
Krugluger, Chemonucleolysis and and automated percutaneous discectomy-a prospective randomized comparison, International Orthopaedics, 2000, vol. 24, pp. 167-169, Springer-Verlag.
Mwale, Biological evaluation of chitosan salts cross-linked genipin as a cell scaffold for disk tissue engineering, Tissue Eng., 2005, Jan.-Feb. 11 (1-2):130-40.
Serhan Hassan
Slivka Michael Andrew
Audet Maury
DePuy Acromed, Inc.
DiMauro Thomas M.
Tsang Cecilia J.
LandOfFree
Method for nonsurgical treatment of the intervertebral disc... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for nonsurgical treatment of the intervertebral disc..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for nonsurgical treatment of the intervertebral disc... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3888160